Mitochondrial dysfunction and cell senescence: deciphering a complex relationship
Open accessAbstract
Cellular senescence and mitochondrial dysfunction have both been defined as classical hallmarks of the ageing process. Here, we review the intricate relationship between the two. In the context of ageing, it is now well regarded that cellular senescence is a key driver in both ageing and the onset of a number of age‐related pathologies. Emerging evidence has pinpointed mitochondria as one of the key modulators in the development of the senescence phenotype, particularly the pro‐inflammatory senescence associated secretory phenotype (SASP). This review focuses on the contribution of homeostatic mechanisms, as well as of reactive oxygen species and mitochondrial metabolites in the senescence programme. Furthermore, we discuss emerging pathways and mitochondrial‐mediated mechanisms that may be influencing the SASP and, subsequently, explore how these may be exploited to open up new therapeutic avenues.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased oxidative stress in senescent cells is linked to dysfunctional mitochondria, and senescent cells show changes in mitochondrial mass, membrane potential and morphology.
“Increased oxidative stress in senescent cells has been linked to the accumulation of dysfunctional mitochondria. Indeed, senescent cells are characterized by changes in mitochondrial mass, membrane potential and mitochondrial morphology46”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [46]
Experimental — accuracy not yet measuredAn increase in ROS/RNS levels can be determined by mitochondrial dysfunctions and can contribute to telomere damage and epigenetic modifications.
“an increase in ROS/RNS levels can be determined by mitochondrial dysfunctions, and this can contribute to telomere damage and epigenetic modifications [27]”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [27]
Cellular senescence is a major mechanism of aging at the cellular level, though likely not the only one.
“Cellular senescence has been described as a major mechanism for aging at the cellular level, although likely not the only mechanism.”
From Reducing Senescent Cell Burden in Aging and Disease (2020) · cites this paper as [17]
Cellular senescence is a primary aging process and tumor suppressive mechanism with features including irreversible growth arrest, apoptosis resistance, SASP, mitochondrial dysfunction, and DNA/chromatin changes.
“Cellular senescence is a primary aging process and tumor suppressive mechanism characterized by irreversible growth arrest, apoptosis resistance, production of a senescence-associated secretory phenotype (SASP), mitochondrial dysfunction, and alterations in DNA and chromatin.”
From Reducing Senescent Cell Burden in Aging and Disease (2020) · cites this paper as [17]
Multiple inducers of cellular senescence include DNA damage, reactive metabolites, inflammation, oncogenes, mitogens, proteotoxic stress, and damage-associated molecular patterns.
“There are multiple inducers of cellular senescence, including DNA damage, reactive metabolites, inflammation, oncogenes, mitogens, proteotoxic stress, and damage-associated molecular patterns [16–18].”
From Reducing Senescent Cell Burden in Aging and Disease (2020) · cites this paper as [17]
Compared with normal proliferating or quiescent cells, senescent cells have increased mitochondrial mass, decreased mitochondrial membrane potential, potentially altered mitophagy, and increased mitochondrial ROS.
“Compared to normal proliferating or quiescent cells, senescent cells have increased mitochondrial mass, decreased mitochondrial membrane potential, potentially altered mitophagy, and increased levels of mitochondrial reactive oxygen species (Chapman et al., 2019).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Chapman et al., 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 125 · Cited by 325
- Authors
- Chapman, J., Fielder, E., & Passos, J. F.
- Affiliations
- Newcastle University (GB)
- Mayo Clinic (US)
- Corresponding author
- Passos, João F.
- Venue
- FEBS Letters
- Publisher
- Wiley
- Published
- 2019-06-27
- Volume
- 593
- Issue
- 13
- Pages
- 1566-1579
- ISSN
- 0014-5793 (ISSN-L)
- 1873-3468
- OpenAlex
- W2950768628
- Cited by
- 325
- References
- 125
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 49 · 2023: 58 · 2022: 57 · 2021: 58 · 2020: 25 · 2019: 4
- FWCI
- 4.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- FEBS Letters (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Biotechnology and Biological Sciences Research Council (BB/H022384/1, BB/K017314/1)
- Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, mitochondrial dysfunction, aging, senescence-associated secretory phenotype, reactive oxygen species, mitochondrial metabolites, mitochondrial homeostasis, age-related diseases, anti-senescence therapy
- MeSH terms
- Aging, Animals, Humans, Mitochondria, Phenotype, Cellular Senescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review